2018 Corporate Excellence Awards Supplement

118 CORPORATE VISION / Corporate Excellence Awards 2018 36 C RP RATE VISI / Issue 6 2018 , POCMedical Systems, is a five- year-old healthcare technology start-up with a disruptive platform called Pandora CDx TM for rapid screening of diseases. We invited Founder, Sanjeev Saxena to tell us more about the company and the services that it offers. Next-Generation Diagnostics for a Better Life POC Medical Systems is led by an experienced management team with the backing of a strong board of directors, cutting edge scientific advisory board, and blue-chip investors. It’s first application, the MammoAlert TM is developed for the early detection of breast cancer. The MammoAlert TM - Pandora CDx TM system has been designed to provide a cost effective, reliable test to enable population screening in developing countries and bring about 100% survival rates for Stage 1 breast cancer in developed countries. Any woman over the age of 30 can be screened safely and periodically using this minimally invasive test. The Pandora CDx TM is a scalable and a flexible platform enabling new applications for various life-threatening diseases where early screening will make a paramount difference in the quality of one’s life. Today, of the 1.6 Billion women only 60 million women are screened for Breast Cancer using the standard of care – Mammography. Of these 2.5 million women are found to have cancer and every year 0.5 million women die since they are detected too late. Just imagine how many women actually have Breast cancer and how many die every year without even realising it. While Mammography is needed to do a definitive diagnosis along with Biopsy a more simple, low cost portable and rugged easy to use system was required for screening the 1.5 Billion women who never get screened. Hence the MammoAlert TM on the Pandora CDx TM . Sanjeev starts off the discussion by outlining the firm’s overall mission, before stating what steps the team will undertake in order to ensure that they will achieve this vision. “POC Medical Systems was set up with a larger goal ‘To save lives’, by addressing the dire need for creating medical diagnostics technology platform for screening cancer, cardiac and infectious diseases, that is reliable, portable and accessible to every person living, even in the remotest corners of the world at a very low cost. We have achieved this by the development of a state-of-the-art product designed specifically for this purpose.” With the medical industry becoming increasingly competitive thanks to the advancement of technology, it is vital for POC Medical Systems that it is able to separate itself apart from its competitors. Sanjeev comments on what attributes the team possess which will help the company distinguish itself as the standout leader in the medical sector. “There is no other technology today for accurate early screening for breast cancer that is minimally invasive and at a low cost. POC Medical System’s differentiates itself with its disruptive technology platform which is targeted to provide point-of-care screening rapidly, efficiently and effortlessly using a minimally invasive and safe technique. The screening tool will enable ‘distributed but connected point-of- care’ screening and diagnostics to bring a paradigm shift in the way breast cancer will be treated in the world.” 1805CV22 Currently, the diagnostic market is beginning to see big changes, and Sanjeev points us towards the global market predictions, as well as stating the importance of women getting screened early for breast cancer, as the diagnosis rate rises. “Moving forward, the global market for point-of-care diagnostic market is projected to climb from USD 23.71 Billion in 2017 to USD 38.13 Billion by 2022, at a CAGR of 10% during the forecast period. The largest sector of diagnostics forecasted is in the breast cancer segment, due to the high incidence rate of breast cancer triggering the need for early screening and diagnostic tools. In 2016, North America dominated the global space with the largest revenue share of more than 41%. Asia Pacific is expected to emerge as the fastest growing region during the forecast period. “The growing incidence and deaths in India and China due to lack of early screening and a favourable regulatory framework, will pave way for a promoting large market growth in this part of the world. There are about